Cargando…
Evaluation of high-dose aspirin elimination in the treatment of Kawasaki disease in the incidence of coronary artery aneurysm
BACKGROUND: Standard first-step therapy for Kawasaki disease consists of Intravenous immunoglobulin and high dose Aspirin (80-100 mg/kg/day). The standard dose of Intravenous immunoglobulin (2gr/kg) is strongly effective in reducing the risk of coronary arteries abnormalities. So, the proper dose an...
Autores principales: | Sanati, Farima, Bagheri, Mohammadmehdi, Eslami, Shahryar, Khalooei, Ali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8174624/ https://www.ncbi.nlm.nih.gov/pubmed/34103852 http://dx.doi.org/10.4103/apc.APC_206_20 |
Ejemplares similares
-
Coronary artery aneurysm in Kawasaki disease
por: Donuru, Achala, et al.
Publicado: (2020) -
Segmented Coronary Artery Aneurysms and Kawasaki Disease
por: Moghadam, Mohammad Yoosef Aarabi, et al.
Publicado: (2011) -
Duration of High-Dose Aspirin Therapy does not Affect Long-Term Coronary Artery Outcomes in Kawasaki Disease
por: Migally, Karl, et al.
Publicado: (2018) -
High risk of coronary artery aneurysm in Kawasaki disease
por: Mossberg, Maria, et al.
Publicado: (2020) -
Effect of different doses of aspirin on the prognosis of Kawasaki disease
por: Wang, Jinxin, et al.
Publicado: (2020)